Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term prognosis of patients with pulmonary hypertension: a preliminary observational study.

AIMS We have previously demonstrated that [(18)F]fluorodeoxyglucose (FDG) accumulation is increased in the right ventricular (RV) free wall of patients with pulmonary hypertension (PH), and that this accumulation is ameliorated after the treatment with epoprostenol associated with improvement of haemodynamic overload. The aim of this study was to examine whether enhanced RV FDG accumulation by gated positron emission tomography (PET) has a prognostic impact in patients with PH. METHODS AND RESULTS We examined the prognostic impact of the RV standardized uptake value (SUV) of FDG-PET corrected for the partial volume effect (cRV-SUV) in 27 patients with PH who underwent gated FDG-PET from March 2001 to June 2004. During the follow-up period of 69 ± 49 (mean ± SD) months, among the 27 patients, 15 showed clinical worsening (CW) and 11 died. FDG-PET examination showed that cRV-SUV was significantly higher in the CW group compared with the non-CW group (10.1 vs. 7.6, P = 0.02). Univariate Cox hazard analysis showed that cRV-SUV was significantly correlated with the time to CW (hazard ratio 1.25, 95% confidence interval 1.04-1.51, P = 0.02), which remained significant even after adjustment of World Health Organization functional class. Kaplan-Meier analysis showed that the patients with cRV-SUV ≥8.3 had poor prognosis compared with those with cRV-SUV <8.3 (log-rank P = 0.005 for time to CW and P = 0.07 for mortality). CONCLUSION These results indicate that enhanced FDG accumulation in the RV free wall may be a novel prognostic factor in patients with PH.

[1]  M. Gatzoulis,et al.  [Updated clinical classification of pulmonary hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[2]  H. Shimokawa,et al.  Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[3]  W. Cornwell,et al.  Pulmonary arterial hypertension. , 2011, Current problems in cardiology.

[4]  A. Einstein,et al.  PET Imaging May Provide a Novel Biomarker and Understanding of Right Ventricular Dysfunction in Patients With Idiopathic Pulmonary Arterial Hypertension , 2011, Circulation. Cardiovascular imaging.

[5]  N. Ozdemir,et al.  Increased Right Ventricular Glucose Metabolism in Patients With Pulmonary Arterial Hypertension , 2011, Clinical nuclear medicine.

[6]  Yoshihiro Fukumoto,et al.  Recent progress in the management of pulmonary hypertension. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[7]  K. Williams,et al.  Relation Between Right Ventricular Function and Increased Right Ventricular [18F]Fluorodeoxyglucose Accumulation in Patients With Heart Failure , 2011, Circulation. Cardiovascular imaging.

[8]  Sindhu R. Johnson,et al.  Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. , 2010, Respiratory medicine.

[9]  Christopher S Coffey,et al.  Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.

[10]  M. Humbert,et al.  Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology , 2010, European Respiratory Review.

[11]  Sanjiv J. Shah,et al.  Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation , 2009, European Respiratory Journal.

[12]  P. van der Harst,et al.  Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[13]  T. Fleming,et al.  End points and clinical trial design in pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.

[14]  S. Hunt,et al.  Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure , 2008, Circulation.

[15]  J. Bronzwaer,et al.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. , 2007, European heart journal.

[16]  W. Klepetko,et al.  Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension , 2007, Circulation.

[17]  Stefan Neubauer,et al.  The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.

[18]  M. Gladwin,et al.  Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. , 2006, Circulation.

[19]  J. Loscalzo,et al.  Pulmonary arterial hypertension. , 2004, Annals of medicine.

[20]  William C Stanley,et al.  Myocardial substrate metabolism in the normal and failing heart. , 2005, Physiological reviews.

[21]  Y. Kagaya,et al.  Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. , 2005, Journal of the American College of Cardiology.

[22]  O. Sabri,et al.  Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  D. Mccrory,et al.  Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[24]  A. Shillington,et al.  Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy , 2002, Circulation.

[25]  P. Herrero,et al.  Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[26]  G. Koch,et al.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[27]  P Stanko,et al.  An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  Y. Kagaya,et al.  Long-term right ventricular volume overload increases myocardial fluorodeoxyglucose uptake in the interventricular septum in patients with atrial septal defect. , 2000, Circulation.

[29]  S. Hamada,et al.  Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  S. Neubauer,et al.  Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. , 1997, Circulation.

[31]  Y. Sawada,et al.  Detection of impaired fatty acid metabolism in right ventricular hypertrophy: Assessment by I-123 β-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial single-photon emission computed tomography , 1997, Annals of nuclear medicine.

[32]  Y. Kagaya,et al.  Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat. , 1995, Cardiovascular research.

[33]  M. Christe,et al.  Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. , 1994, Journal of molecular and cellular cardiology.

[34]  G. Lopaschuk,et al.  Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. , 1994, The American journal of physiology.

[35]  J. Sandoval,et al.  Survival in primary pulmonary hypertension. Validation of a prognostic equation. , 1994, Circulation.

[36]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[37]  R. Hines.  Right ventricular function and failure: a review. , 1991, The Yale journal of biology and medicine.

[38]  Y. Kanno,et al.  Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. A quantitative autoradiographic study. , 1990, Circulation.